期刊文献+

左炔诺孕酮宫内缓释系统临床应用及疗效评价 被引量:2

Clinical Application and Evaluation of Levonorgestrel-releasing Intrauterine System
下载PDF
导出
摘要 目的:探讨左炔诺孕酮宫内缓释系统(LNG-IUS)临床应用及发生下移后上推复位的效果。方法:对152例放置LNG-IUS患者进行随访,了解痛经程度、月经量变化及LNG-IUS在宫腔的位置。对45例LNG-IUS下移者采用超声引导上推复位术。结果:放置LNG-IUS第6个月与放置前比较视觉模拟评分法(VAS)评分和失血量图形分析评分法(PBAC)评分差异有统计学意义(t=2.15,P<0.05;t=142.63,P<0.01)。LNG-IUS下移45例(29.6%),经上推复位治疗后,42例仍继续使用。结论:LNG-IUS是治疗功能性子宫出血及子宫腺肌病相关疼痛及月经过多的有效方法之一。LNG-IUS使用中下移经超声引导上推复位术是安全可行的。 Objective: To observe the clinical application of levonorgestrel-releasing intrauterine system(LNG-IUS),and to evaluate the effeciency of resetting the downward shifted LNG-IUS.Methods:Total 152 patients with LNG-IUS were follow-up visited,to assess the degree of dysmenorrheal,the extent of menstrual bleeding and the position of LNG-IUS in uterine.The reposition under the guidance of B ultrasound were performed in 45 cases with ectopic LNG-IUS.Results:Both VAS grade and PBAC grade after inserting the LNG-IUS were significantly lowered when compared with their pre-deposited grades(t=2.15,P〈0.05;t=142.63,P〈0.01).Of the 45 cases undergoing reposition(29.6%),42 cases were still using the device.Conclusions: LNG-IUS is one of the effective treatments for dysfunctional uterine bleeding and adenomyosis of uterus.The reposition of the downward shifted LNG-IUS under the guidance of B ultrasound is safe and feasible.
出处 《国际生殖健康/计划生育杂志》 CAS 2013年第4期247-249,共3页 Journal of International Reproductive Health/Family Planning
关键词 宫内避孕器 宫内避孕器排出 宫内避孕器 含药 功能性子宫出血 子宫内膜异位症 月经过多 Intrauterine devices Intrauterine device expulsion Intrauterine devices medicated Functional uterine bleeding Endometriosis Menorrhagia
  • 相关文献

参考文献9

二级参考文献63

  • 1何淑明,韦明秀,韩燕华,何立红.左炔诺孕酮宫内缓释系统治疗子宫腺肌病的临床观察[J].中华妇产科杂志,2005,40(8):536-538. 被引量:115
  • 2盛洁,卢丹,张建萍,崔桂芬.左炔诺孕酮宫内释放系统治疗子宫腺肌病痛经的临床观察[J].中华妇产科杂志,2006,41(7):467-470. 被引量:83
  • 3肖碧莲 高纪 等.月经血量的测定方法[J].中华妇产科杂志,1980,15(3):159-60.
  • 4Rutanen EM. Endometrial response to intrauterine release of levonorgestrel. Gynecol Forum, 1998, 3(1): 11-14.
  • 5Luukkainen T, Pakarinen P, Toivonen J. Progestin-releasing intrauterine system. Semi Reprod Med, 2001, 19(4): 355-363.
  • 6Zalel Y, Shulman A, Lidor A, et al. The local progestational efffect of the levonorgestrel-releasing intrauterine system: a sonographic and Doppler flow study. Hum Reprod, 2002, 17(11):2878-2880.
  • 7Guillebaud .I. The levnorgestrel intrauterine systemL: a clinical perspective from the UK. Ann N Y Acad Sci, 2003, 997(2): 185-193.
  • 8Backman T, Huhtala S, Luoto R, et al. Advance information improves improves user satisfaction with the levonorgestrel intrauterine system.Obstet Gynecol, 2002, 99(4): 608-613.
  • 9French R, Cowan F, Mansour D, et al. Hormonally impregnated intrauterine systems(IUSs) versus other forms of reversible contraceptives as effective methods of preventing pregnancy. Cochrane Database Syst Rev, 2001,(2):CD001776.
  • 10Backman T, Rauramo I, Huhtala S, et al. Pregancy during the use of levonorgestrel intrauterine system. Am J Obstet Gynecol, 2004, 190(1):50-54.

共引文献540

同被引文献12

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部